Roivant Sciences (ROIV) Gross Profit (2020 - 2026)
Roivant Sciences (ROIV) reported Gross Profit of $1.16 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 42.6% from $2.02 million a year earlier and down 47.4% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Gross Profit (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Roivant Sciences' Gross Profit came in at $6.12 million, down 72.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $6.98 million, down 75.2% from FY2025.
- Gross Profit has a five-year compound annual growth rate of -20.3% (FY2021 to FY2026).
- By fiscal year, Gross Profit came in at $28.14 million in FY2025 (-9.6%), $31.11 million in FY2024 (+9.2%), $28.5 million in FY2023 (-38.5%) and $46.32 million in FY2022 (+113.1%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Gross Profit since fiscal Q2 2021.
- Year over year, Gross Profit has now declined in each of the last seven quarters, with an average decline of 46.7% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was fiscal Q1 2024 (growth of 571.4%); the low point was fiscal Q3 2026 (a decline of 85.2%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $2.2 million (Q4 2026), $1.3 million (Q3 2026) and $1.46 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Roivant Sciences | 27.06 Bn | 10.70 Bn | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 8.76 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 7.78 Mn |
| Mar 31, 2024 | 8.82 Mn |
| Dec 31, 2023 | 15.37 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 17.41 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 13.47 Mn |
| Sep 30, 2022 | 8.89 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 8.76 Mn |
| Dec 31, 2021 | 22.96 Mn |
| Sep 30, 2021 | 7.61 Mn |
API Access
Roivant Sciences Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();